Japanese Pharma Firm Joins Pfizer and Merck in Race to Develop COVID Pill Cure

A Japanese company has started human trials of the first once-a-day pill for COVID-19 patients, joining Pfizer Inc. and Merck & Co. in the race to find treatments for the disease. Well, we know that whoever wins the race will be greatly appreciated, so keep it up!

Read more about it

Photo Credit: James Yarema

10 views0 comments